In a report released today, William Bonello from Craig-Hallum reiterated a Buy rating on Guardant Health (GH – Research Report), with a price ...
BTIG analyst Mark Massaro reiterated a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $60.00. The ...
A new wave of techno-optimist patriotism and rising geopolitical tensions are driving more venture capital investing to defense tech startups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback